GSK3β

Danmei Zhang1, Chunxia Shi1, Qingqi Zhang1

  • 1Department of Infectious Diseases, Renmin Hospital of Wuhan University, No. 238 Jiefang Road, Wuhan, Hubei province, 430060, China.

概括

使用TDZD-8抑制糖原合成酶激酶3β (GSK3β) 通过减少细胞死亡,有效治疗急性肝衰竭 (ALF). 这种保护作用与TRAF6/HDAC3/TAK1通路有关,为ALF提供了潜在的治疗策略.